-transparent.png){kind=logo}
The serum zinc concentration seems unlikely to be an important factor influencing immune response to hepatitis B vaccination in hemodialysis patients, on the basis of the following results: the absence of statistically significant differences in serum zinc concentrations between patients with absence of post-vaccine seroconversion or non protective seroconversion and patients with excellent seroconversion (anti-HBs concentrations over 124.6 mUI/ml); the association of protective antibody responses in 50% of non responders after an additional dose of HBV vaccine, without preliminary corrections of zinc balance.
Related Publications
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
January 1987,
Nephron,
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
February 1994,
Clinical nephrology,
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
July 2013,
Nephro-urology monthly,
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
May 2015,
Journal of clinical medicine research,
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
January 1988,
Nephron,
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
December 2011,
Minerva medica,
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
January 2022,
Wiadomosci lekarskie (Warsaw, Poland : 1960),
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
February 2015,
World journal of hepatology,
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
November 1995,
Lancet (London, England),
G Migneco, and
S Tripi, and
A Navetta, and
A La Ferla, and
F Vaccaro
July 1990,
The International journal of artificial organs,
